|
Volumn 338, Issue 6108, 2012, Pages 750-752
|
Emerging disease or diagnosis?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DISEASE PREVALENCE;
INFECTIOUS DISEASE;
VIRAL DISEASE;
EBOLA HEMORRHAGIC FEVER;
EBOLA VIRUS;
EPIDEMIC;
GENETIC ASSOCIATION;
HUMAN;
LASSA FEVER;
LASSA VIRUS;
NONHUMAN;
PATHOGENICITY;
PREVALENCE;
PRIORITY JOURNAL;
SEROPREVALENCE;
SHORT SURVEY;
AFRICA SOUTH OF THE SAHARA;
ANIMAL;
ARTICLE;
BLOOD;
COMMUNICABLE DISEASE;
COMMUNITY CARE;
DISEASE CARRIER;
DISEASE RESISTANCE;
DISEASE TRANSMISSION;
EPIDEMIOLOGY;
GENETICS;
IMMUNOLOGY;
MOLECULAR EVOLUTION;
PRIMATE;
PRIMATE DISEASE;
VIROLOGY;
VIRUS HEMORRHAGIC FEVER;
VIRUS ANTIBODY;
AFRICA SOUTH OF THE SAHARA;
ANIMALS;
ANTIBODIES, VIRAL;
COMMUNICABLE DISEASES, EMERGING;
COMMUNITY HEALTH SERVICES;
DISEASE OUTBREAKS;
DISEASE RESERVOIRS;
DISEASE RESISTANCE;
EBOLAVIRUS;
EVOLUTION, MOLECULAR;
HEMORRHAGIC FEVER, EBOLA;
HEMORRHAGIC FEVERS, VIRAL;
HUMANS;
LASSA FEVER;
LASSA VIRUS;
PREVALENCE;
PRIMATE DISEASES;
PRIMATES;
SEROEPIDEMIOLOGIC STUDIES;
|
EID: 84868519350
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.1225893 Document Type: Short Survey |
Times cited : (26)
|
References (17)
|